Weekly Commentary: The Question

The Nasdaq 100 enjoyed one of those well-timed Friday afternoon rallies (1.9% off morning trading lows) to somewhat ease ...
Investor's Business Daily on MSN

Biotech Leader BeOne Medicines Eyes New Buy Point As Cancer Drug Sales Surge

BeOne stock is approaching a new buy point following the company's strong third-quarter report that saw cancer drug sales surge.